Core Insights - The conference themed "Star Towards the Universe, Beauty Reborn" marks the launch of Candela's new Glacē Treatment and emphasizes the integration of classic technology with innovative approaches in the medical aesthetics industry [1][18]. Group 1: Company Vision and Commitment - Candela's Asia-Pacific Senior Vice President, Indra Suardi, highlighted the company's 55-year history focused on advancing medical aesthetics through technology and collaboration with doctors to create a better future [3]. - The conference serves as a commitment to the future of the industry, with a call to continue refining products and creating new opportunities together by 2026 [3]. Group 2: Clinical Insights and Expert Contributions - Experts shared their clinical experiences with Candela's classic technologies, including Professor Zhou Guoyu's discussion on the effectiveness of Vbeam pulsed dye laser in treating vascular diseases [5]. - Dr. Li Xiaoning presented insights on the comprehensive rejuvenation effects of Gentle long pulse dual-wavelength laser based on five years of clinical practice [6]. - Dr. Qian Lihan emphasized the importance of building high-value photon projects by leveraging technology advantages and service differentiation [6]. - Dr. Su Mingshan discussed the advancements and advantages of PicoWay laser in treating pigmentary diseases in Asian skin [8]. Group 3: Academic and Operational Forums - The "Insight · Frontier" academic forum featured discussions on the clinical applications and innovative boundaries of classic technologies, with contributions from various industry leaders [10][12]. - The "Dialogue · Win-Win" operational forum focused on transforming technological value into sustainable business dynamics, with insights on operational strategies and customer retention [13][14]. Group 4: New Product Launch and Market Strategy - The Glacē Treatment, launched at the conference, introduces a "3 IN 1 full-cycle care" concept aimed at expanding Candela's reach into lifestyle beauty scenarios [18]. - Candela's market strategy for 2026 emphasizes building a "smart medical aesthetics ecosystem" through academic support, resource integration, and the launch of innovative products [14][24]. - The company aims to enhance customer satisfaction and retention through unique technologies that meet diverse skincare needs [20][22]. Group 5: Industry Collaboration and Future Outlook - Candela's approach combines the legacy of classic technologies with new explorations in dual beauty integration, fostering collaboration among physicians, institutions, and consumers for sustainable industry growth [24].

Core Viewpoint - The skincare industry is increasingly integrating with medical aesthetics, with products like eye creams and moisturizers claiming to deliver results comparable to professional treatments, offering consumers effective, convenient, and safe alternatives to invasive procedures [3][4][16]. Group 1: Industry Trends - Brands are collectively launching "clinic-level" skincare products, blurring the lines between home care and medical aesthetics, raising questions about the definition of "effective" skincare [4][16]. - The demand for "clinic-level" products is driven by consumers seeking high efficacy without the invasiveness and cost of medical procedures, reflecting a shift in consumer preferences towards more accessible skincare solutions [19][22]. Group 2: Technological Innovations - The industry is focusing on three main technological pathways: ingredient replication, transdermal technology, and efficacy validation to bridge the gap between professional medical aesthetics and daily skincare [5][11]. - Ingredient replication involves incorporating medical-grade ingredients into skincare products, such as PDRN, which traditionally required injection for effectiveness but is now being formulated for topical use [5][7]. - Transdermal technology advancements aim to enhance the absorption of active ingredients, allowing skincare products to penetrate deeper into the skin without invasive methods [9][11]. Group 3: Efficacy Validation - Brands are increasingly relying on robust efficacy data to support their claims, conducting human efficacy tests and correlating results with medical aesthetic procedures to build consumer trust [11][13]. - The lack of a unified efficacy validation system poses challenges, as current testing methods and metrics vary, making it difficult to compare results with established medical treatments [27][29]. Group 4: Market Dynamics - The light medical aesthetics market in China has seen a compound annual growth rate (CAGR) of over 20% from 2018 to 2023, with projections indicating it will exceed 250 billion RMB by 2025 [20]. - The integration of medical aesthetics and skincare is becoming a significant trend, with brands exploring collaborations and innovations that combine both fields to meet consumer demands for effective and safe skincare solutions [24][28]. Group 5: Consumer Behavior - Consumers are becoming more discerning, seeking scientific evidence and efficacy data behind claims of products that promise results similar to medical treatments, indicating a maturation of the market [26][29]. - The shift towards "clinic-level" skincare reflects a broader trend of consumers desiring effective, convenient, and safe alternatives to traditional medical aesthetics, creating a new ecosystem in the beauty industry [24][29].

Core Viewpoint - The article discusses the launch of Estée Lauder's new eye cream, the "Micro-Sculpting Eye Cream," which aims to bridge the gap between cosmetic and medical beauty, addressing long-standing consumer pain points in eye care and leading the trend of dual beauty integration [3][4][28]. Market Context - The eye care market in China is experiencing rapid growth and intense competition, with increasing consumer demand for youthful appearance, particularly among younger demographics and men [23][24]. - The market for eye care products is evolving from basic moisturizing tools to "precise anti-aging solutions," driven by the integration of medical aesthetics and daily care [23][24]. Product Launch and Features - Estée Lauder's new eye cream is positioned as a "clinic-level anti-aging" product that simulates three major cosmetic procedures: Botox, Thermage, and hyaluronic acid fillers [16][27]. - The cream incorporates advanced technologies, including a blend of peptides and hyaluronic acid, to achieve effects similar to those of medical procedures without the associated side effects [16][19][20]. Consumer Insights - The demand for eye area rejuvenation is increasing, with consumers prioritizing safety, long-lasting effects, and comprehensive anti-aging solutions [6][12]. - The product aims to empower consumers to take proactive steps in their daily skincare routines, moving away from reliance on medical procedures [27][28]. Scientific Backing - Clinical trials presented at a leading dermatology conference demonstrated the effectiveness of the new eye cream in improving the appearance of the eye area, with significant percentages of participants reporting visible improvements [21][20]. - The product's formulation is supported by over 40 years of research and development in nighttime repair and eye care, establishing a strong scientific foundation for its claims [24][27]. Competitive Positioning - Despite competition from domestic brands and white-label products, Estée Lauder maintains a leading position in the eye care market, evidenced by its top sales figures in online platforms [23][24]. - The brand's long-standing commitment to research and innovation has allowed it to stay at the forefront of the eye care segment, continuously adapting to market trends and consumer needs [24][27].

Core Viewpoint - The beauty industry is increasingly entering the medical aesthetics channel, with over 20 beauty brands adopting a dual beauty strategy of "medical aesthetics + beauty" to enhance their market presence and professional credibility [2][6][30]. Group 1: Market Overview - The medical aesthetics market in China is experiencing strong growth, with 18,584 compliant specialized medical aesthetics institutions reported as of January 2024 [6][7]. - The main active regions for medical aesthetics consumption are concentrated in the Pearl River Delta, Yangtze River Delta, and Chengdu-Chongqing areas [7][8]. Group 2: Industry Structure - Medical aesthetics institutions can be categorized into three types: public hospitals, large chain private hospitals, and small private hospitals and clinics [4][5]. - The development of the domestic medical aesthetics industry has gone through three main stages: initiation (1994-2000), gradual standardization (2000-2010), and rapid development (2010-present) [5]. Group 3: Brand Strategies - Many beauty companies have established significant medical aesthetics channel layouts, such as Huaxi Biological covering 7,000 medical institutions and Juzhi Biological entering approximately 1,700 public hospitals and 3,000 private hospitals and clinics [8][10]. - International beauty brands are also accelerating their medical aesthetics channel expansion, with brands like SkinCeuticals and Estée Lauder entering high-end medical aesthetics lines [10][12]. Group 4: Consumer Trends - There is a growing consumer demand for effective skincare solutions that combine beauty products with medical treatments, reflecting a trend towards the integration of lifestyle beauty and medical aesthetics [17][20]. - Consumers are increasingly seeking products with professional medical backing and comprehensive management solutions from pre-operative care to post-operative recovery [18][20]. Group 5: Challenges and Opportunities - Despite the initial success of some brands in the medical aesthetics channel, challenges remain, including product quality inconsistency and the need for effective consumer education [16][18][20]. - The dual beauty model is becoming a significant trend, with medical aesthetics companies also venturing into lifestyle beauty, leveraging their technical expertise and clinical data [22][23]. Group 6: Future Outlook - The competition in the medical aesthetics channel is expected to intensify, with beauty brands needing to establish unique advantages through solid technical research and deep medical collaboration [29][30]. - The future winners in this space will be those who can embed "professional trust" in the medical aesthetics channel and leverage "real clinical value" to gain endorsements from both doctors and consumers [30].